...
首页> 外文期刊>Tropical biomedicine. >Enhanced production of short-peptide tagged Ss3a recombinant protein as a novel potential biomarker for strongyloidiasis
【24h】

Enhanced production of short-peptide tagged Ss3a recombinant protein as a novel potential biomarker for strongyloidiasis

机译:增强的短肽标记的SS3A重组蛋白作为一种用于抗酮化病的新型潜在生物标志物

获取原文
           

摘要

Strongyloidiasis is a mysterious yet important parasitic disease that is hard to diagnose. While microscopic examination remains a "controversial" gold standard method, improved diagnosis is achieved through confirmatory assays with serological and/or molecular diagnostic approaches. In the current serodiagnosis of strongyloidiasis, recombinant proteins have been adopted in place of the use of native parasite antigens, although the availability of diagnostically potential proteins are still limited. Here, we introduce a novel Strongyloides recombinant protein that is uniquely attached to two different short peptide tags as a potential diagnostic biomarker for serodiagnosis of strongyloidiasis, namely lysine (7K) and aspartic acid (7D). The work presented focus on improving the yield and purity of the previously unexpressed recombinant protein. Preliminary diagnostic evaluation of the recombinant favors Ss3a7K protein owing to its higher antigenicity performance with 80% sensitivity and 100% specificity, respectively.
机译:强肌腱病是一种神秘而重要的寄生疾病,难以诊断。虽然微观检查仍然是“争议”的黄金标准方法,但通过具有血清学和/或分子诊断方法的确认测定来实现改善的诊断。在目前的抗酮血管腺炎的血糖诊断中,已经采用了重组蛋白代替使用天然寄生虫抗原,尽管诊断潜在的蛋白质仍然有限。在这里,我们介绍一种新的酮基体重组蛋白,其唯一地附着在两个不同的短肽标签中,作为抗酮化病变,即赖氨酸(7k)和天冬氨酸(7d)的血型诊断生物标志物。该工作呈现了重点,提高预先抑制的重组蛋白的产量和纯度。由于其较高的抗原性能,分别具有80%敏感性和100%特异性的初步诊断SS3A7K蛋白的初步诊断评价。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号